Delivery Order SPE2DB20D3101-SPE2DB25FRSD1
Award Date 8/8/25
Potential Completion Date 8/11/25
Potential Value $1.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $4,131.41 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Dexamethasone 0.5 mg/5 mL elixir in a 237 mL quantity, with ultimate completion scheduled for July 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $4,707.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexamethasone 20 mg/5 mL vials on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled from the vendor's facility in...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp., a subsidiary of Amerisourcebergen Corporation, to provide 237 mL bottles of 0.5 mg/5 mL dexamethasone elixir. The $1,231.40 award has a completion date of February 5, 2024. Amerisourcebergen Drug Corp. is a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. This...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Dexamethasone 120 mg/30 ml vials with a ceiling value of $1,050.40. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 11, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Dexamethasone 20 mg/5 mL vials with a ceiling value of $1,343.25. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open competition process. The order is scheduled for completion by August 4, 2025, and will be fulfilled from the contractor's operations in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of dexamethasone 20 mg/5 ml vials. The $2,997.21 order is to be completed by January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to provide pharmaceutical products and medical supplies to DLA Troop...
- This is a $2,547.92 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The order is for the delivery of DEXAMETHASONE 0.5 MG/5 ML ELX 237ML, a medication, with a performance period ending on May 29, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,182.24, is for the delivery of 4,566,189,769 milliliters of dexamethasone 10 mg/mL vials. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of October 25, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of dexamethasone 20 mg/5 ml vial, a critical pharmaceutical product. The $2,376.00 firm-fixed-price contract has a performance period through September 24, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and there is no set-aside designation. This order is likely part of a larger Indefinite Delivery Contract (IDC) between...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,754.98 firm fixed-price delivery order is for the supply of 4,565,586,405 units of 20 mg/5 mL dexamethasone vials. The contract has an ultimate completion date of August 27, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...